Metraipolis › archive › dc_bdb2ffe02dc2

CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy — Europe PMC PMID:41008900

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41008900
DOI: 10.3390/cancers17183058
License (as archived): solo-consultazione
Archived: 2026-11-09T21:45:09.771Z
SHA-256 of the archived text: 43c86189fc537ddd49272e94f30b6af9975386239e5d7a88396dde5a5595006f
Stable URL of this page: https://metraipolis.com/documento/dc_bdb2ffe02dc2

How to cite

CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy — Europe PMC PMID:41008900 — Europe PMC (en), https://europepmc.org/article/MED/41008900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bdb2ffe02dc2 (Metraipolis archive dc_bdb2ffe02dc2, sha256 43c86189fc537ddd49272e94f30b6af9975386239e5d7a88396dde5a5595006f)

BibTeX

@misc{dcbdb2ffe02dc2,
  title = {CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy — Europe PMC PMID:41008900},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008900},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bdb2ffe02dc2; sha256 43c86189fc537ddd49272e94f30b6af9975386239e5d7a88396dde5a5595006f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008900. Agents can read the archived copy with the MCP tool read_document.